Candida glabrata: New tools and technologies-expanding the toolkit

FEMS Yeast Research

Volumn 15, Issue 6, 2015, Pages

  Ho, Hsueh Lui ^a   Haynes, Ken ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

Candida; Candida glabrata; S. cerevisiae; Technologies; Tools; virulence

Indexed keywords

CANDIDA GLABRATA; VIRULENCE; ANIMAL; CANDIDIASIS; DISEASE MODEL; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIAL GENETICS; MICROBIOLOGY; MOLECULAR BIOLOGY; PATHOLOGY; PROCEDURES; TRENDS;

VIRULENCE FACTOR;

ANIMALS; CANDIDA GLABRATA; CANDIDIASIS; DISEASE MODELS, ANIMAL; GENETICS, MICROBIAL; HUMANS; MOLECULAR BIOLOGY; VIRULENCE; VIRULENCE FACTORS;

EID: 84949233845     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1093/femsyr/fov066     Document Type: Short Survey

References (131)

1. Ahmad KM, Kokošar J, Guo X, et al. Genome structure and dynamics of the yeast pathogen Candida glabrata. FEMS Yeast Res 2014;14:529-35.
2. Akbari OS, Oliver D, Eyer K, et al. An entry/gateway cloning system for general expression of genes with molecular tags in Drosophila melanogaster. BMC Cell Biol 2009;10: 8. Alarco A-M, Marcil A, Chen J, et al. Immune-deficient Drosophila melanogaster: a model for the innate immune response to human fungal pathogens. J Immunol 2004;172:5622-8.
3. Alarco A-M, Marcil A, Chen J, et al. Immune-deficient Drosophila melanogaster: a model for the innate immune response to human fungal pathogens. J Immunol 2004;172:5622-8
4. Alexander BD, Johnson MD, Pfeiffer CD, et al. Increasing echinocandin resistance in candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 2013;56: 1724-32.
5. Annaluru N, Muller H, Mitchell LA, et al. Total synthesis of a functional designer eukaryotic chromosome. Science 2014;344: 55-8.
6. Aoyama T, Nakayama H, Ueno K, et al. Genome-wide survey of transcriptional initiation in the pathogenic fungus, Candida glabrata. Genes Cells 2014;19:478-503.
7. Bao Z, Xiao H, Liang J, et al. Homology-integrated CRISPR-Cas (HICRISPR) system for one-step multigene disruption in Saccharomyces cerevisiae. ACS Synth Biol 2015;4:585-94.
8. Becker JM, Kauffman SJ, Hauser M, et al. Pathway analysis of Candida albicans survival and virulence determinants in a murine infection model. P Natl Acad Sci USA 2010;107: 22044-9.
9. Bergin D, Brennan M, Kavanagh K. Fluctuations in haemocyte density and microbial loadmay be used as indicators of fungal pathogenicity in larvae of Galleria mellonella. Microbes Infect 2003;5:1389-95.
10. Brand A, MacCallum DM, Brown AJP, et al. Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus. Eukaryot Cell 2004;3: 900-9.
11. Brennan M, Thomas DY, Whiteway M, et al. Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae. FEMS Immunol Med Mic 2002;34:153-7.
12. Breslow DK, Cameron DM, Collins SR, et al. A comprehensive strategy enabling high-resolution functional analysis of the yeast genome. Nat Methods 2008;5:711-8.
13. Brothers KM, Newman ZR, Wheeler RT. Live imaging of disseminated candidiasis in zebrafish reveals role of phagocyte oxidase in limiting filamentous growth. Eukaryot Cell 2011;10:932-44.
14. Brunke S, Hube B. Two unlike cousins: Candida albicans and C. glabrata infection strategies. Cell Microbiol 2013;15:701-8.
15. Brunke S, Quintin J, Kasper L, et al. Of mice, flies - and men? Comparing fungal infection models for large-scale screening efforts. Dis Model Mech 2015;8:473-86.
16. Brunke S, Seider K, Fischer D, et al. One small step for a yeast-microevolution within macrophages renders Candida glabrata hypervirulent due to a single point mutation. PLoS Pathog 2014;10:e1004478.
17. Calcagno A-M, Bignell E, Warn P, et al. Candida glabrata STE12 is required for wild-type levels of virulence and nitrogen starvation induced filamentation. Mol Microbiol 2003;50:1309-18.
18. Castano I, Kaur R, Pan S, et al. Tn7-based genome-wide random insertionalmutagenesis of Candida glabrata. Genome Res 2003;13:905-15.
19. Castaño I, Pan S-J, ZupancicM, et al. Telomere length control and transcriptional regulation of subtelomeric adhesins in Candida glabrata. Mol Microbiol 2005;55:1246-58.
20. Cen Y, Fiori A, Van Dijck P. Deletion of the DNA ligase IV gene in Candida glabrata significantly increases gene-targeting efficiency. Eukaryot Cell 2015;14:783-91.
21. Chamilos G, Lionakis MS, Lewis RE, et al. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. J Infect Dis 2006;193:1014-22.
22. Chan TF, Carvalho J, Riles L, et al. A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR). P Natl Acad Sci USA 2000;97:13227-32.
23. Chao C-C, Hsu P-C, Jen C-F, et al. Zebrafish as a model host for Candida albicans infection. Infect Immun 2010;78:2512-21.
24. Chauvel M, Nesseir A, Cabral V, et al. A versatile overexpression strategy in the pathogenic yeast Candida albicans: identification of regulators of morphogenesis and fitness. PLoS One 2012;7:e45912.
25. Cohen SN, Chang ACY, Boyer HW, et al. Construction of biologically functional bacterial plasmids in vitro. P Natl Acad Sci USA 1973;70:3240-4.
26. Cormack BP, Ghori N, Falkow S. An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science (80-) 1999;285:578-82.
27. Corrigan MW, Kerwin-Iosue CL, Kuczmarski AS, et al. The fate of linear DNA in Saccharomyces cerevisiae and Candida glabrata: the role of homologous and non-homologous end joining. PLoS One 2013;8:e69628.
28. Costanzo M, Baryshnikova A, Bellay J, et al. The genetic landscape of a cell. Science 2010;327:425-31.
29. Cotter G, Doyle S, Kavanagh K. Development of an insect model for the in vivo pathogenicity testing of yeasts. FEMS Immunol Med Mic 2000;27:163-9.
30. Crook NC, Schmitz AC, Alper HS. Optimization of a yeast RNA interference system for controlling gene expression and enabling rapid metabolic engineering. ACS Synth Biol 2014;3:307-13.
31. Csank C, Haynes K. Candida glabrata displays pseudohyphal growth. FEMS Microbiol Lett 2000;189:115-20.
32. Csank C, Makris C, Meloche S, et al. Derepressed hyphal growth and reduced virulence in a VH1 family-related protein phosphatasemutant of the human pathogen Candida albicans. Mol Biol Cell 1997;8:2539-51.
33. Da Silva Ferreira ME, Kress MRVZ, Savoldi M, et al. The akuB(KU80)mutant deficient for nonhomologous end joining is a powerful tool for analyzing pathogenicity in Aspergillus fumigatus. Eukaryot Cell 2006;5:207-11.
34. Dai J, Hyland EM, Yuan DS, et al. Probing nucleosome function: a highly versatile library of synthetic histone H3 and H4 mutants. Cell 2008;134:1066-78.
35. De Groot PWJ, Kraneveld EA, Yin QY, et al. The cell wall of the human pathogen Candida glabrata: differential incorporation of novel adhesin-like wall proteins. Eukaryot Cell 2008;7: 1951-64.
36. De Las Peñas A, Pan S-J, Castanõ I, et al. Virulence-related surface glycoproteins in the yeast pathogen Candida glabrata are encoded in subtelomeric clusters and subject to RAP1-and SIR-dependent transcriptional silencing. Gene Dev 2003;17: 2245-58.
37. Diekema D, Arbefeville S, Boyken L, et al. The changing epidemiology of healthcare-associated candidemia over three decades. Diagn Micr Infec Dis 2012;73:45-8.
38. Doudna JA, Charpentier E. The newfrontier of genome engineering with CRISPR-Cas9. Science (80-) 2014;346:1258096-6.
39. Drinnenberg IA, Weinberg DE, Xie KT, et al. RNAi in budding yeast. Science 2009;326:544-50.
40. Dujon B, Sherman D, Fischer G, et al. Genome evolution in yeasts. Nature 2004;430:35-44.
41. Fidel PL, Ginsburg KA, Cutright JL, et al. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen. J Infect Dis 1997;176: 728-39.
42. Fidel PLJ, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999;12:80-96.
43. Flagfeldt DB, Siewers V, Huang L, et al. Characterization of chromosomal integration sites for heterologous gene expression in Saccharomyces cerevisiae. Yeast 2009;26: 545-51.
44. Fuchs BB, Eby J, Nobile CJ, et al. Role of filamentation in Galleria mellonella killing by Candida albicans. Microbes Infect 2010a;12:488-96.
45. Fuchs BB, Mylonakis E. Using non-mammalian hosts to study fungal virulence and host defense. Curr Opin Microbiol 2006;9:346-51.
46. Fuchs BB, O'Brien E, Khoury JB El, et al. Methods for using Galleria mellonella as a model host to study fungal pathogenesis. 2010b;Virulence 1:475-82.
47. Gelperin DM, White MA, Wilkinson ML, et al. Biochemical and genetic analysis of the yeast proteome with a movable ORF collection. Gene Dev 2005;19:2816-26.
48. Ghaemmaghami S, Huh W-K, Bower K, et al. Global analysis of protein expression in yeast. Nature 2003;425:737-41.
49. Giaever G, Chu AM, Ni L, et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature 2002;418:387-91.
50. Gilles AF, Averof M. Functional genetics for all: engineered nucleases, CRISPR and the gene editing revolution. Evodevo 2014;5:43.
51. Glittenberg MT, Kounatidis I, Christensen D, et al. Pathogen and host factors are needed to provoke a systemic host response to gastrointestinal infection of Drosophila larvae by Candida albicans. Dis Model Mech 2011a;4:515-25.
52. Glittenberg MT, Silas S, MacCallum DM, et al. Wild-type Drosophila melanogaster as an alternative model system for investigating the pathogenicity of Candida albicans. Dis Model Mech 2011b;4:504-14.
53. Goffeau A, Barrell BG, Bussey H, et al. Life with 6000 genes. Science 1996;274:546, 563-7.
54. Gouy M, Guindon S, Gascuel O. SeaView Version 4: A multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol Biol Evol 2010;27:221-4.
55. Gratacap RL, Wheeler RT. Utilization of zebrafish for intravital study of eukaryotic pathogen-host interactions. Dev Comp Immunol 2014;46:108-15.
56. Gregori C, Schüller C, Roetzer A, et al. The high-osmolarity glycerol response pathway in the human fungal pathogen Candida glabrata strain ATCC 2001 lacks a signaling branch that operates in baker's yeast. Eukaryot Cell 2007;6:1635-45.
57. Haas BJ, Zeng Q, PearsonMD, et al. Approaches to fungal genome annotation. Mycology 2011;2:118-41.
58. Hartley JL. DNA cloning using in vitro site-specific recombination. Genome Res 2000;10:1788-95.
59. Hensel M, Shea J, Gleeson C, et al. Simultaneous identification of bacterial virulence genes by negative selection. Science (80-) 1995;269:400-3.
60. Huh W-K, Falvo JV, Gerke LC, et al. Global analysis of protein localization in budding yeast. Nature 2003;425: 686-91.
61. Inglis DO, Arnaud MB, Binkley J, et al. The Candida genome database incorporates multiple Candida species: multispecies search and analysis tools with curated gene and protein information for Candida albicans and Candida glabrata. Nucleic Acids Res 2012;40:D667-74.
62. Ito T, Chiba T, Ozawa R, et al. A comprehensive two-hybrid analysis to explore the yeast protein interactome. P Natl Acad Sci USA 2001;98:4569-74.
63. Jacobs JZ, Ciccaglione KM, Tournier V, et al. Implementation of the CRISPR-Cas9 system in fission yeast. Nat Commun 2014;5:5344.
64. Jacobsen ID, Brunke S, Seider K, et al. Candida glabrata persistence in mice does not depend on host immunosuppression and is unaffected by fungal amino acid auxotrophy. Infect Immun 2010;78:1066-77.
65. Janke C, Magiera MM, Rathfelder N, et al. A versatile toolbox for PCR-based tagging of yeast genes: new fluorescent proteins, more markers and promoter substitution cassettes. Yeast 2004;21:947-62.
66. Kasper L, Seider K, Gerwien F, et al. Identification of Candida glabrata genes involved in pH modulation and modification of the phagosomal environment in macrophages. PLoS One 2014;9:e96015.
67. Kaur R, Castanõ I, Cormack BP. Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata: roles of calcium signaling and mitochondria. Antimicrob Agents Ch 2004;48:1600-13.
68. Kaur R, Ma B, Cormack BP. A family of glycosylpho sphatidylinositol-linked aspartyl proteases is required for virulence of Candida glabrata. P Natl Acad Sci USA 2007;104:7628-33.
69. Kavanagh K, Reeves EP. Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens. FEMS Microbiol Rev 2004;28:101-12.
70. Kemmeren P, Kockelkorn TTJP, Bijma T, et al. Predicting gene function through systematic analysis and quality assessment of high-throughput data. Bioinformatics 2005;21: 1644-52.
71. KershawMJ, Talbot NJ. Genome-wide functional analysis reveals that infection-associated fungal autophagy is necessary for rice blast disease. P Natl Acad Sci USA 2009;106:15967-72.
72. Kim D-U, Hayles J, Kim D, et al. Analysis of a genome-wide set of gene deletions in the fission yeast Schizosaccharomyces pombe. Nat Biotechnol 2010;28:617-23.
73. Kim H, Kim J-S. A guide to genome engineering with programmable nucleases. Nat Rev Genet 2014;15:321-34.
74. Kobrynski LJ, Tanimune L, Kilpatrick L, et al. Production of Thelper cell subsets and cytokines by lymphocytes from patients with chronic mucocutaneous candidiasis. Clin Diagn Lab Immun 1996;3:740-5.
75. Krogh-Madsen M, Arendrup MC, Heslet L, et al. Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient. Clin Infect Dis 2006;42: 938-44.
76. Kumar A, Agarwal S, Heyman JA, et al. Subcellular localization of the yeast proteome. Gene Dev 2002;16:707-19.
77. Kuo Z-Y, Chuang Y-J, Chao C-C, et al. Identification of infectionand defense-related genes via a dynamic host-pathogen interaction network using a Candida albicans-zebrafish infection model. J Innate Immun 2013;5:137-52.
78. La Sala A, Urbani F, Torosantucci A, et al. Mannoproteins from Candida albicans elicit a Th-type-1 cytokine profile in human Candida specific long-term T cell cultures. J Biol Reg Homeos Ag 1996;10:8-12.
79. Laganà A, Shasha D, Croce CM. Synthetic RNAs for gene regulation: design principles and computational tools. Front Bioeng Biotechnol 2014;2:65.
80. Lay J, Henry LK, Clifford J, et al. Altered expression of selectable marker URA3 in gene-disrupted Candida albicans strains complicates interpretation of virulence studies. Infect Immun 1998;66:5301-6.
81. Leberer E, Harcus D, Broadbent ID, et al. Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans. P Natl Acad Sci USA 1996;93:13217-22.
82. Leigh JE, Steele C, Wormley FL, et al. Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis. J Acq Immun Def Synd 1998;19:373-80.
83. Lemaitre B, Nicolas E, Michaut L, et al. The Dorsoventral regulatory gene cassette controls the potent antifungal response in Drosophila adults. Cell 1996;86:973-83.
84. Linde J, Duggan S, Weber M, et al. Defining the transcriptomic landscape of Candida glabrata by RNA-Seq. Nucleic Acids Res 2015;43:1392-406.
85. Ma J, Bharucha N, Dobry CJ, et al. Localization of autophagyrelated proteins in yeast using a versatile plasmid-based resource of fluorescent protein fusions. Autophagy 2008;4:792-800.
86. MacCallum DM, Findon H, Kenny CC, et al. Different consequences of ACE2 and SWI5 gene disruptions for virulence of pathogenic and nonpathogenic yeasts. Infect Immun 2006;74:5244-8.
87. Mali P, Esvelt KM, Church GM. Cas9 as a versatile tool for engineering biology. Nat Methods 2013;10:957-63.
88. Mnaimneh S, Davierwala AP, Haynes J, et al. Exploration of essential gene functions via titratable promoter alleles. Cell 2004;118:31-44.
89. Moran C, Grussemeyer CA, Spalding JR, et al. Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections. Am J Infect Control 2010;38:78-80.
90. Morgan J, Meltzer MI, Plikaytis BD, et al. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Cont Hosp Ep 2005;26:540-7.
91. Muller H, Hennequin C, Gallaud J, et al. The asexual yeast Candida glabrata maintains distinct a and alpha haploid mating types. Eukaryot Cell 2008;7:848-58.
92. Nookaew I, Papini M, Pornputtapong N, et al. A comprehensive comparison of RNA-Seq-based transcriptome analysis from reads to differential gene expression and cross-comparison with microarrays: a case study in Saccharomyces cerevisiae. Nucleic Acids Res 2012;40:10084-97.
93. Panayidou S, Ioannidou E, Apidianakis Y. Human pathogenic bacteria, fungi, and viruses in Drosophila: disease modeling, lessons, and shortcomings. Virulence 2014;5: 253-69.
94. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-35.
95. Pelz RK, Lipsett PA, Swoboda SM, et al. Candida infections: outcome and attributable ICU costs in critically Ill patients. J Intensive Care Med 2000;15:255-61.
96. Pfaller MA, Castanheira M, Lockhart SR, et al. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J Clin Microbiol 2012;50:1199-203.
97. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007;20:133-63.
98. Pfaller MA, Diekema DJ, Gibbs DL, et al. Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program. Diagn Micr Infec Dis 2010;67:162-71.
99. Quintin J, Asmar J, Matskevich AA, et al. The Drosophila Toll pathway controls but does not clear Candida glabrata infections. J Immunol 2013;190:2818-27.
100. Reboul J, Vaglio P, Rual J-F, et al. C. elegans ORFeome version 1.1: experimental verification of the genome annotation and resource for proteome-scale protein expression. Nat Genet 2003;34:35-41.
101. Rocha CRC, Schroppel K, Harcus D, et al. Signaling through adenylyl cyclase is essential for hyphal growth and virulence in the pathogenic fungus Candida albicans. Mol Biol Cell 2001;12:3631-43.
102. Roetzer A, Gratz N, Kovarik P, et al. Autophagy supports Candida glabrata survival during phagocytosis. Cell Microbiol 2010;12:199-216.
103. Roetzer A, Gregori C, Jennings AM, et al. Candida glabrata environmental stress response involves Saccharomyces cerevisiae Msn2/4 orthologous transcription factors. Mol Microbiol 2008;69:603-20.
104. Romani L. Innate and adaptive immunity in Candida albicans infections and saprophytism. J Leukocyte Biol 2000;68: 175-9.
105. Romani L, Bistoni F, Puccetti P. Initiation of T-helper cell immunity to Candida albicans by IL-12: the role of neutrophils. Chem Immunol 1997;68:110-35.
106. Rosas-Herńandez LL, Jú arez-Reyes A, Arroyo-Helguera OE, et al. yKu70/yKu80 and Rif1 regulate silencing differentially at telomeres in Candida glabrata. Eukaryot Cell 2008;7:2168-78.
107. Ross-Macdonald P, Coelho PS, Roemer T, et al. Large-scale analysis of the yeast genome by transposon tagging and gene disruption. Nature 1999;402:413-8.
108. Sander JD, Joung JK. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 2014;32:347-55.
109. Schwarzmüller T, Ma B, Hiller E, et al. Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes. PLoS Pathog 2014;10:e1004211.
110. Seider K, Brunke S, Schild L, et al. The facultative intracellular pathogen Candida glabrata subverts macrophage cytokine production and phagolysosome maturation. J Immunol 2011;187:3072-86.
111. Shalem O, Sanjana NE, Zhang F. High-throughput functional genomics using CRISPR-Cas9. Nat Rev Genet 2015;16:299-311.
112. Sidhu YS, Cairns TC, Usher J, et al. Exploitation of sulfonylurea resistance marker and non- homologous end joining mutants for functional analysis in Zymoseptoria tritici. Fungal Genet Biol 2015;79:102-9.
113. Silva S, Negri M, Henriques M, et al. Adherence and biofilm formation of non-Candida albicans Candida species. Trends Microbiol 2011;19:241-7.
114. Skrzypek MS, Hirschman J. Using the Saccharomyces Genome Database (SGD) for analysis of genomic information. Current Protocols in Bioinformatics 2011;35:1.20:1.20.1-1.20.23.
115. Sopko R, Huang D, Preston N, et al. Mapping pathways and phenotypes by systematic gene overexpression. Mol Cell 2006;21:319-30.
116. Steinmetz LM, Scharfe C, Deutschbauer AM, et al. Systematic screen for human disease genes in yeast. Nat Genet 2002;31:400-4.
117. Suter B, Fetchko MJ, Imhof R, et al. Examining protein protein interactions using endogenously tagged yeast arrays: the cross-and-capture system. Genome Res 2007;17:1774-82.
118. Szabo EK, MacCallum DM. The contribution of mouse models to our understanding of systemic candidiasis. FEMS Microbiol Lett 2011;320:1-8.
119. Tarassov K, Messier V, Landry CR, et al. An in vivo map of the yeast protein interactome. Science 2008;320:1465-70.
120. Thorne TW, Ho HL, Huvet M, et al. Prediction of putative protein interactions through evolutionary analysis of osmotic stress response in the model yeast Saccharomyces cerevisae. Fungal Genet Biol 2011;48:504-11.
121. Tong AH, Evangelista M, Parsons AB, et al. Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science 2001;294:2364-8.
122. Tsai IJ, Tanaka E, Masuya H, et al. Comparative genomics of Taphrina fungi causing varying degrees of tumorous deformity in plants. Genome Biol Evol 2014;6:861-72.
123. Ueno K, Uno J, Nakayama H, et al. Development of a highly efficient gene targeting system induced by transient repression of YKU80 expression in Candida glabrata. Eukaryot Cell 2007;6:1239-47.
124. Varshney N, Schaekel A, Singha R, et al. A surprising role for the Sch9 Protein Kinase in chromosome segregation in Candida albicans. Genetics 2015;199:671-4.
125. Villalba F, Collemare J, Landraud P, et al. Improved gene targeting in Magnaporthe grisea by inactivation of MgKU80 required for non-homologous end joining. Fungal Genet Biol 2008;45:68-75.
126. Vyas VK, Barrasa MI, Fink GR. A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families. Sci Adv 2015;1:e1500248-8.
127. West L, Lowman DW, Mora-Montes HM, et al. Differential virulence of Candida glabrata glycosylation mutants. J Biol Chem 2013;288:22006-18.
128. Wickerham LJ. Apparent increase in frequency of infections involving Torulopsis glabrata: procedure for its identification. JAMA 1957;165:47-8.
129. Wilson LS, Reyes CM, Stolpman M, et al. The direct cost and incidence of systemic fungal infections. Value Heal 2002;5:26-34.
130. Winzeler EA, Shoemaker DD, AstromoffA, et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 1999;285:901-6.
131. Zalatan JG, Lee ME, Almeida R, et al. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell 2014;160:339-50.